Phase I/II study of preoperative chemoradiotherapy with Gemcitabine and S-1 for resectable pancreatic cancer - Phase I/II study of preoperative chemoradiotherapy with Gemcitabine and S-1 for resectable pancreatic cancer

Multicenter Clinical Study Group of Osaka0 sites63 target enrollmentOctober 19, 2009

Overview

No summary available.

Registry

who.int

Start Date

October 19, 2009

End Date

August 31, 2020

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Multicenter Clinical Study Group of Osaka

•(1\) Unresectable pancreatic cancer (2\) Presence or past history of Interstitial pneumonia or pulmonary fibrosis or possible (3\) Watery diarrhea (4\) Active infections (excluding viral hepatitis) (5\) Severe cardiac disorder, renal disorder, liver disorder, ulcer with bleeding, intestinal tract paralysis, uncontrollable diabetes mellitus (6\) Presence of pleural effusion or ascites requiring drainage (7\) Presence of metastasis in central nervous system (8\) Active double cancer except carcinoma in situ or intramucosal cancer (synchronous double cancer or asynchronous double cancer with disease\-free duration to be within 3 years) (9\) Treatment with phenytoin, potassium warfarin or flucytosine (10\) Pregnant females or nursing mothers who can not stop lactation. Patients or partners, who don't attempt to doing contraception during the study period. (11\) Severe mental disorder (12\) Severe drug hypersensitivity (13\) As determined by the principal investigator or the sub\-investigator the subject is not adequate to participate in the trial.